2-methylsulfanyl-5-quinolin-6-ylmethylene-thiazol-4-one | 872573-94-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-methylsulfanyl-5-quinolin-6-ylmethylene-thiazol-4-one
• 英文别名: (5Z)-2-(methylthio)-5-(6-quinolinylmethylidene)-1,3-thizol-4(5H)-one；(5Z)-2-(methylthio)-5-(6-quinolinylmethylidene)-1,3-thiazol-4(5H)-one；2-methylsulfanyl-5-[1-quinolin-6-yl-meth-(Z)-ylidene]-thiazol-4-one；(5Z)-2-methylsulfanyl-5-(quinolin-6-ylmethylidene)-1,3-thiazol-4-one
• CAS: 872573-94-9
• 化学式: C₁₄H₁₀N₂OS₂
• 分子量: 286.378
• InChiKey: WIJLZYFAEXKBMF-WQLSENKSSA-N

物化性质

• 沸点：
  492.3±55.0 °C(Predicted)
• 密度：
  1.38±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  92.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-methylsulfanyl-5-quinolin-6-ylmethylene-thiazol-4-one 在 sodium hydride 作用下， 以 N-甲基吡咯烷酮 为溶剂， 反应 1.17h， 以8.7%的产率得到(5Z)-2-[(3,5-dichloro-2,6-dimethyl-4-pyridinyl)amino]-5-(6-quinoxalinylmethylidene)-1,3-thiazol-4(5H)-one
  参考文献：
  名称：

  WO2006/127458

  摘要：

  公开号：
• 作为产物：
  描述：

  喹啉-6-甲醛 在 sodium acetate 、 溶剂黄146 、 N,N-二异丙基乙胺 作用下， 以 乙醇 为溶剂， 反应 36.0h， 生成 2-methylsulfanyl-5-quinolin-6-ylmethylene-thiazol-4-one
  参考文献：
  名称：

  Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors

  摘要：

  A novel series of quinolinyl-methylene-thiazolinones has been identified as potent and selective cyclin-dependent kinase I (CDK1) inhibitors. Their synthesis and structure activity relationships (SAR) are described. Representative compounds from this class reversibly inhibit CDK1 activity in vitro, and block cell cycle progression in human tumor cell lines, suggesting a potential use as antitumor agents. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.01.081

文献信息

• Thiazolinone unsubstituted quinolines
  申请人：Chen Li

  公开号：US20060004045A1

  公开（公告）日：2006-01-05

  Thiazolinone quinoline derivatives having no substitution on the quinoline ring active as CDK1 inhibitors which are useful as anti-proliferation agents such as for treating solid tumors.

  噻唑酮喹啉衍生物在喹啉环上没有取代基，作为CDK1抑制剂活性，可用作抗增殖剂，例如用于治疗实体肿瘤。
• [EN] 2-IMINO-4-(THIO) OXO-5-POLY CYCLOVINYLAZOLINES FOR USE AS P13 KINASE IHIBITORS<br/>[FR] 2-IMINO-4-(THIO) OXO-5-POLY CYCLOVINYLAZOLINES UTILISES COMME INHIBITEURS DE P13 KINASE
  申请人：APPLIED RESEARCH SYSTEMS

  公开号：WO2005011686A1

  公开（公告）日：2005-02-10

  The present invention is related to 2-imino-azolinone-vinyl fused-benzene derivatives of Formula (1) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

  本发明涉及Formula (1)中的2-亚胺-氮杂氧杂氮烯-乙烯融合苯衍生物，特别用于治疗和/或预防自身免疫疾病和/或炎症性疾病、心血管疾病、神经退行性疾病、肾脏疾病、血小板聚集、癌症、移植、移植排斥或肺损伤。
• 2-Imino-4-(thio)oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors
  申请人：Rueckle Thomas

  公开号：US20070021447A1

  公开（公告）日：2007-01-25

  The present invention is related to 2-imino-azolinone-vinyl fused-benzene derivatives of Formula (1) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

  本发明涉及公式（1）的2-亚氨基-咪唑酮-乙烯基融合苯衍生物，特别用于治疗和/或预防自身免疫性疾病和/或炎症性疾病、心血管疾病、神经退行性疾病、肾脏疾病、血小板聚集、癌症、移植、移植排斥或肺损伤。
• THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS
  申请人：Dhanak Dashyant

  公开号：US20100216801A1

  公开（公告）日：2010-08-26

  Invented is a method of inhibiting the activity/function of PI3 kinases using substituted thiazolones. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of substituted thiazolones.

  本发明提供了使用取代噻唑酮抑制PI3激酶活性/功能的方法。同时，本发明还提供了一种使用取代噻唑酮治疗自身免疫性疾病、炎症性疾病、心血管疾病、神经退行性疾病、过敏、哮喘、胰腺炎、多器官衰竭、肾脏疾病、血小板聚集、癌症、精子运动能力、移植排斥、移植物排斥和肺部损伤的方法。
• NOVEL CHEMICAL COMPOUNDS
  申请人：Duffy Kevin

  公开号：US20090203692A1

  公开（公告）日：2009-08-13

  This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with hYAK3 activity.

  本发明涉及新鉴定的化合物，用于抑制hYAK3蛋白质，并用于治疗与hYAK3活性相关的疾病的方法。